Although myeloma cells have the characteristics of focal distribution, and M protein in blood or urine is routinely used as an indicator of tumor load and treatment response of MM, it should be more objective to comprehensively evaluate the therapeutic effect if the above two are combined. This evidence concerns the gene MYOM2 and neoplasm.